Suppr超能文献

抗 rAAV6 免疫反应:犬细小病毒疫苗接种和病毒载体新生期给药的影响。

Immune Responses to rAAV6: The Influence of Canine Parvovirus Vaccination and Neonatal Administration of Viral Vector.

机构信息

Medical Scientist Training Program, University of Washington School of Medicine Seattle, WA, USA.

出版信息

Front Microbiol. 2011 Nov 3;2:220. doi: 10.3389/fmicb.2011.00220. eCollection 2011.

Abstract

Recombinant adeno-associated viral (rAAV) vectors promote long-term gene transfer in many animal species. Significant effort has focused on the evaluation of rAAV delivery and the immune response in both murine and canine models of neuromuscular disease. However, canines provided for research purposes are routinely vaccinated against canine parvovirus (CPV). rAAV and CPV possess significant homology and are both parvoviruses. Thus, any immune response generated to CPV vaccination has the potential to cross-react with rAAV vectors. In this study, we investigated the immune response to rAAV6 delivery in a cohort of CPV-vaccinated canines and evaluated multiple vaccination regimens in a mouse model of CPV-vaccination. We show that CPV-vaccination stimulates production of neutralizing antibodies with minimal cross-reactivity to rAAV6. In addition, no significant differences were observed in the magnitude of the rAAV6-directed immune response between CPV-vaccinated animals and controls. Moreover, CPV-vaccination did not inhibit rAAV6-mediated transduction. We also evaluated the immune response to early rAAV6-vaccination in neonatal mice. The influence of maternal hormones and cytokines leads to a relatively permissive state in the neonate. We hypothesized that immaturity of the immune system would permit induction of tolerance to rAAV6 when delivered during the neonatal period. Mice were vaccinated with rAAV6 at 1 or 5 days of age, and subsequently challenged with rAAV6 exposure during adulthood via two sequential IM injections, 1 month apart. All vaccinated animals generated a significant neutralizing antibody response to rAAV6-vaccination that was enhanced following IM injection in adulthood. Taken together, these data demonstrate that the immune response raised against rAAV6 is distinct from that which is elicited by the standard parvoviral vaccines and is sufficient to prevent stable tolerization in neonatal mice.

摘要

重组腺相关病毒(rAAV)载体在许多动物物种中促进长期基因转移。大量的工作集中在 rAAV 传递的评估和免疫反应在鼠和犬神经肌肉疾病模型中。然而,用于研究目的的犬通常接种犬细小病毒(CPV)疫苗。rAAV 和 CPV 具有显著的同源性,都是细小病毒。因此,对 CPV 疫苗接种产生的任何免疫反应都有可能与 rAAV 载体发生交叉反应。在这项研究中,我们研究了 CPV 疫苗接种犬群中 rAAV6 传递的免疫反应,并在 CPV 疫苗接种小鼠模型中评估了多种疫苗接种方案。我们表明,CPV 疫苗接种刺激产生中和抗体,与 rAAV6 的交叉反应最小。此外,CPV 疫苗接种的动物和对照组之间 rAAV6 定向免疫反应的大小没有显著差异。此外,CPV 疫苗接种不会抑制 rAAV6 介导的转导。我们还评估了 rAAV6 早期疫苗接种在新生小鼠中的免疫反应。母体激素和细胞因子的影响导致新生儿处于相对允许的状态。我们假设,当在新生儿期给予 rAAV6 时,免疫系统的不成熟将允许诱导对 rAAV6 的耐受性。在 1 或 5 天大时,用 rAAV6 对小鼠进行疫苗接种,随后在成年期通过两次连续的 IM 注射(间隔 1 个月)接受 rAAV6 暴露挑战。所有接种疫苗的动物对 rAAV6 疫苗接种均产生显著的中和抗体反应,在成年期进行 IM 注射后增强。总之,这些数据表明,针对 rAAV6 产生的免疫反应与由标准细小病毒疫苗引起的免疫反应不同,足以防止新生小鼠的稳定耐受。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c3ee/3207220/ed2c4ae652d0/fmicb-02-00220-g001.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验